首页> 外国专利> PHARMACEUTICAL COMPOSITION CONTAINING AS ACTIVE INGREDIENT 1-METHYL-1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE OR SALT THEREOF

PHARMACEUTICAL COMPOSITION CONTAINING AS ACTIVE INGREDIENT 1-METHYL-1-BENZYL-1,2,3,4-TETRAHYDROISOQUINOLINE OR SALT THEREOF

机译:包含有效成分1-甲基-1-苄基-1,2,3,4-四氢异喹啉或其盐的药物组合物

摘要

PURPOSE:To provide the title composition useful as an anticonvulsant, containing, as active ingredient, 1-methyl-1-benzyl-1,2,3,4-tetrahydroisoquinoline or salt thereof. CONSTITUTION:The objective composition containing, as active ingredient, a compound of the formula, an N-methyl-D-aspartate receptor antagonist, or salt thereof. The present composition is useful as a medicine for the prevention and therapy of nerve degeneration and/or nerve necrosis under such pathological conditions as cerebral ischemia in the case of cardiac standstill or cerebral apoplexy, hypoxia, hypoglycemia, epilepsia and injury; in addition, being expected as a medicine for the prevention and therapy of Alzheimer' s disease. Huntigton's chorea, Parkinson's disease, cerebrovascular dementia, sleep disorder, schizophrenia, melancholia, anxietas, etc.
机译:目的:提供用作抗惊厥剂的标题组合物,其含有1-甲基-1-苄基-1,2,3,4-四氢异喹啉或其盐作为活性成分。组成:目标组合物,包含以下化合物作为活性成分:N-甲基-D-天冬氨酸受体拮抗剂或其盐。本发明的组合物可用作预防和治疗在诸如心脏停顿或脑中风,缺氧,低血糖,癫痫和损伤的情况下的脑缺血等病理条件下的神经变性和/或神经坏死的药物;另外,有望作为预防和治疗阿尔茨海默氏病的药物。亨廷顿舞蹈症,帕金森氏病,脑血管性痴呆,睡眠障碍,精神分裂症,忧郁症,焦虑症等

著录项

  • 公开/公告号JPH03109325A

    专利类型

  • 公开/公告日1991-05-09

    原文格式PDF

  • 申请/专利权人 FUJISAWA PHARMACEUT CO LTD;

    申请/专利号JP19890247637

  • 申请日1989-09-22

  • 分类号C07D217/02;A61K31/47;A61K31/472;A61P3/08;A61P9/00;A61P9/10;A61P9/12;A61P25/00;A61P25/08;A61P25/18;A61P25/20;A61P25/24;A61P25/26;A61P25/28;

  • 国家 JP

  • 入库时间 2022-08-22 06:04:55

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号